147 related articles for article (PubMed ID: 12595626)
1. Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositis.
Chung YL; Wassif WS; Bell JD; Hurley M; Scott DL
Rheumatology (Oxford); 2003 Feb; 42(2):298-303. PubMed ID: 12595626
[TBL] [Abstract][Full Text] [Related]
2. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study.
Cea G; Bendahan D; Manners D; Hilton-Jones D; Lodi R; Styles P; Taylor DJ
Brain; 2002 Jul; 125(Pt 7):1635-45. PubMed ID: 12077012
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid binding protein 3 is associated with skeletal muscle strength in polymyositis and dermatomyositis.
Zhang L; Zhou H; Peng Q; Jiang W; Qiao W; Wang G
Int J Rheum Dis; 2017 Feb; 20(2):252-260. PubMed ID: 26891180
[TBL] [Abstract][Full Text] [Related]
4. In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: a preliminary study.
Chung YL; Smith EC; Williams SC; Wassif WS; Salisbury JR; Simmons A; Howlett DC; Scott DL
Eur J Med Res; 1997 Nov; 2(11):483-7. PubMed ID: 9385119
[TBL] [Abstract][Full Text] [Related]
5. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
[TBL] [Abstract][Full Text] [Related]
6. T2 mapping in dermatomyositis/polymyositis and correlation with clinical parameters.
Ran J; Ji S; Morelli JN; Wu G; Li X
Clin Radiol; 2018 Dec; 73(12):1057.e13-1057.e18. PubMed ID: 30172348
[TBL] [Abstract][Full Text] [Related]
7. Role of bone scan in the assessment of polymyositis/dermatomyositis.
An YS; Suh CH; Jung JY; Kim HA
Clin Rheumatol; 2015 Apr; 34(4):699-706. PubMed ID: 25501462
[TBL] [Abstract][Full Text] [Related]
8. Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study.
Shimojima Y; Ishii W; Matsuda M; Tazawa K; Ikeda S
BMC Musculoskelet Disord; 2012 Nov; 13():228. PubMed ID: 23173570
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
[TBL] [Abstract][Full Text] [Related]
10. Quality of life correlates with muscle strength in patients with dermato- or polymyositis.
Poulsen KB; Alexanderson H; Dalgård C; Jacobsen S; Weile L; Diederichsen LP
Clin Rheumatol; 2017 Oct; 36(10):2289-2295. PubMed ID: 28585061
[TBL] [Abstract][Full Text] [Related]
11. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
[TBL] [Abstract][Full Text] [Related]
12. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients.
Koh ET; Seow A; Ong B; Ratnagopal P; Tjia H; Chng HH
Ann Rheum Dis; 1993 Dec; 52(12):857-61. PubMed ID: 8311535
[TBL] [Abstract][Full Text] [Related]
13. Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies.
Chung YL; Rider LG; Bell JD; Summers RM; Zemel LS; Rennebohm RM; Passo MH; Hicks J; Miller FW; Scott DL;
Arthritis Rheum; 2005 Aug; 53(4):565-70. PubMed ID: 16082628
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.
Peng QL; Shu XM; Tian XL; Lu X; Wang GC
Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773
[TBL] [Abstract][Full Text] [Related]
15. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.
Tateyama M; Fujihara K; Misu T; Arai A; Kaneta T; Aoki M
BMJ Open; 2015 Jan; 5(1):e006763. PubMed ID: 25582454
[TBL] [Abstract][Full Text] [Related]
16. An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis.
Huang ZG; Gao BX; Chen H; Yang MX; Chen XL; Yan R; Lu X; Shi KN; Chan Q; Wang GC
PLoS One; 2017; 12(7):e0181069. PubMed ID: 28715432
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases.
Scola RH; Werneck LC; Prevedello DM; Toderke EL; Iwamoto FM
Arq Neuropsiquiatr; 2000 Sep; 58(3B):789-99. PubMed ID: 11018813
[TBL] [Abstract][Full Text] [Related]
18. Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis.
Mattar MA; Gualano B; Perandini LA; Shinjo SK; Lima FR; Sá-Pinto AL; Roschel H
Arthritis Res Ther; 2014 Oct; 16(5):473. PubMed ID: 25344395
[TBL] [Abstract][Full Text] [Related]
19. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
20. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis.
Alexanderson H; Stenström CH; Jenner G; Lundberg I
Scand J Rheumatol; 2000; 29(5):295-301. PubMed ID: 11093595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
